Submission Details
| 510(k) Number | K210293 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 02, 2021 |
| Decision Date | March 03, 2021 |
| Days to Decision | 29 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K210293 is an FDA 510(k) clearance for the AtriClip LAA Exclusion System, a Left Atrial Appendage Clip, Implantable (Class II — Special Controls, product code PZX), submitted by AtriCure, Inc. (West Chester, US). The FDA issued a Cleared decision on March 3, 2021, 29 days after receiving the submission on February 2, 2021. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 878.4300.
| 510(k) Number | K210293 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 02, 2021 |
| Decision Date | March 03, 2021 |
| Days to Decision | 29 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | PZX — Left Atrial Appendage Clip, Implantable |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 878.4300 |
| Definition | Intended To Occlude The Left Atrial Appendage. |